Drug profile · INN
triamcinolone hexacetonide
ARISTOSPAN
triamcinolone hexacetonide (ARISTOSPAN) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — triamcinolone hexacetonide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
triamcinolone hexacetonide (ARISTOSPAN) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is triamcinolone hexacetonide?
triamcinolone hexacetonide (ARISTOSPAN) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for triamcinolone hexacetonide?
ARISTOSPAN is a marketed brand name for triamcinolone hexacetonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triamcinolone hexacetonide?
triamcinolone hexacetonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.